| |
|
 |
DGRA INTRANET |
 |
| |
| |
 |
|
| Internal information for members.
|
 |
|
| |
|
 |
BUSINESS OFFICE: |
 |
| |
| |
 |
|
Adenauerallee 15
D-53111 Bonn,
Germany
Phone: +49 (0)228 368264-6
Fax: +49 (0)228 368264-7
E-Mail: info@dgra.de
|
 |
|
|
|
 |
| DRUG REGULATORY AFFAIRS COURSE |
 |
| Module 4: General aspects of Module 1 (CTD) and authorisation of specific medicines
Method of examination: Course work Credit points: 5
Module Head: Dr. Christine Mayer-Nicolai
| 1 |
Abridged / Generic Applications with emphasis on administrative processes and content of the dossier in module 1
- Essentially similar and informed consent applications
- Bibliographical Application
- Content of the dossier (modules 1, 2 and specific aspects for modules 3 and 4)
- Line-extensions
- Scientific Advice at the BfArM
- The marketing authorization application form
Exercise on the application form |
| 2 |
National applications at BfArM (Pr�fung nationaler Zulassungsantr�ge im BfArM)
- Assessment process, e.g. efficacy (Wirksamkeitspr�fung)
- Clinical Trial reports according to Annex one of Directive 2001/83, Clinical Summary and Overview, relevant aspects in the assessment of clinical part of the dossier, fixed combinations
- Summary of Product Characteristics (SmPC)
- Company Core Data Sheet
- Package leaflet and consultation with target patient groups
- Labelling (Kennzeichnung)
- Specific BfArM requirements (Besonderheiten in den Anforderungen des BfArM und zugeh�rige Bekanntmachungen)
- Labelling principles in national phases of EU procedures
|
| 3 |
Veterinary products
- Definitions
- Veterinary Legislation in Germany, EU and globally
- EMEA, CVMP, HMA and CMD(v), VICH, Animal Health Industry Associations
- Specific aspects of the SmPC
- Parts of a Dossier - Part I, II, IIIA Safety, IIIB Residues, IV
- Withdrawal Periods
- Ecotoxicity
|
| 4 |
Vaccines
- Definitions and specific aspects
- Combinations
- Influenza vaccines
- Authorization procedure (brief introduction)
- Vaccine Antigen Master File (VAMF)
|
| 5 |
Advanced Therapies
- Relevant Directives, Regulations, Guidelines
- Definition and classification: advanced therapy medicinal products, tissue products, combined products
- Authorization procedures
- Incentives
|
| 6 |
Blood products
- Specific regulatory aspects for Blood components
- Official Batch Release
- Specific requirements for marketing authorization of blood products (example coagulation factors)
- Plasma Master File
Exercise on blood products |
| 7 |
Specific aspects in marketing applications procedures for herbal and homeopathic medicinal products (Arzneimittel der besonderen Therapierichtungen)
- Definitions
- Requirements (AMG, AMPr�fRL, pharmacopoeas)
- Possible MAA/registration procedures and required data on S, Q, E
- Herbal medicinal products, HMPWP, Botanical nomenclature, Extracts (labeling)
- Homeopathic medicinal products: The homeopathic principle, manufacturing according to PhEur
- Registration procedure
- Anthroposophical products (brief introduction)
| |
| |
| « back |
| |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
 |
|
|
 |
© 2011, DGRA e.V.
Letzte Aktualisierung am: Dienstag, 08.02.2011
|
|
|